Journal article · 2023
Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination
Advanced Healthcare Materials, 12(22), e2202871 · Published 14 June 2023 · DOI 10.1002/adhm.202202871
In brief
“Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination” is a 2023 journal article by Yingmin Li and 5 co-authors, published in Advanced Healthcare Materials. OpenAlex counts 40 citations as of 21 November 2026, which puts it in the top 7% of works published in 2023 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 40
- Most cited in
- 2025 (17)
- Field-weighted impact
- 3.62
- References
- 43
- Authors
- 6
Abstract
In situ vaccines have revolutionized immunotherapy as they can stimulate tumor-specific immune responses, with the cancer being the antigen source. However, the heterogeneity of tumor antigens and insufficient dendritic cells (DCs) activation result in low cancer immunogenicity and hence poor vaccine response. Herein, a new in situ vaccine composed of acid-responsive liposome-coated polydopamine (PDA) nanoparticles… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Li, Y., Luo, Y., Hou, L., Huang, Z., Wang, Y., & Zhou, S. (2023). Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination. Advanced Healthcare Materials, 12(22), e2202871. https://doi.org/10.1002/adhm.202202871
MLA 9
Li, Yingmin, et al. “Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination.” Advanced Healthcare Materials, vol. 12, no. 22, 2023, p. e2202871. https://doi.org/10.1002/adhm.202202871.
Chicago
Li, Yingmin, Yang Luo, Lamei Hou, Zhengjie Huang, Yi Wang, and Shaobing Zhou. 2023. “Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination.” Advanced Healthcare Materials 12 (22): e2202871. https://doi.org/10.1002/adhm.202202871.
Harvard
Li, Y. et al. (2023) ‘Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination’, Advanced Healthcare Materials, 12(22), p. e2202871. doi:10.1002/adhm.202202871.
IEEE
Y. Li, Y. Luo, L. Hou, Z. Huang, Y. Wang, and S. Zhou, “Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination,” Advanced Healthcare Materials, vol. 12, no. 22, p. e2202871, 2023, doi: 10.1002/adhm.202202871.
BibTeX
@article{li2023antigen,
title = {{Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination}},
author = {Li, Yingmin and Luo, Yang and Hou, Lamei and Huang, Zhengjie and Wang, Yi and Zhou, Shaobing},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {22},
pages = {e2202871},
doi = {10.1002/adhm.202202871},
url = {https://doi.org/10.1002/adhm.202202871}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 13 | |
| 2025 | 17 | |
| 2026 | 9 |
Its field-weighted citation impact is 3.62: it has been cited 3.62 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- in situ tumor vaccination
- dendritic cell targeting
- photothermal therapy
- polydopamine nanoparticles
- resiquimod
- acid-responsive drug release
- immunogenic cell death
- tumor-associated antigens
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Li, Y., Luo, Y., Hou, L., Huang, Z., Wang, Y., & Zhou, S. (2023). Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ Vaccination. Advanced Healthcare Materials, 12(22), e2202871. https://doi.org/10.1002/adhm.202202871
How many times has this paper been cited?
40 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Yingmin Li, Yang Luo, Lamei Hou, Zhengjie Huang, Yi Wang, Shaobing Zhou.
What is the DOI of this paper?
10.1002/adhm.202202871, permanently at https://doi.org/10.1002/adhm.202202871. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.